Albi Melatonin 3 mg capsules
Natural health product licensed in Canada
- Licence holder
- Bona Vita Holdings Inc.
- NPN or DIN-HM
- 80002516
- Status
- Active licence
- Licence date
- 15 December 2006
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-[2-(5-méthoxyindol-3-yl)éthyl] acétamide | 3 mg | Not calculated |
Non-medicinal ingredients
Croscarmellose de sodium, Stéarate de magnésium, Cellulose, microcristalline, Gélatine, Phosphate de dicalcium dihydrate
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 3 Capsule | Not specified |
Uses authorised in Canada
Helps increase the total sleep time in people suffering from sleep restriction or altered sleep schedule. Helps relieve the daytime fatigue associated with jet lag. Helps to reduce the time it takes to fall asleep in people with delayed sleep phase syndrome. Helps re-set the body's sleep-wake cycle.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are taking immunosuppressive drugs. Do not drive or use heavy machinery for 5 hours after taking melatonin. Do not use if you are pregnant or breastfeeding.
- Précautions et mises en garde
Consult a health care pratitioner prior to use if you have a hormonal disorder, diabetes, liver or kidney disease, cerebral palsey, seizure disorders, migraine, depression and/or hypertension or if you are taking blood pressure or sedative/hypnotic medications. Symptoms persist continuously for more than 4 weeks (chronic insomnia), consult your health care practitioner.
Source
Official Health Canada record, licence 80002516
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.